Insider · CIK 0001327897

Mendelson Daniel Newman

CIK 0001327897 Name as filed on the most recent filing

Filed as Mendelson Daniel Newman (31)

36 transaction lines · from 31 filings · filed 2014-03-21 to 2024-01-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

36 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-01-12 P, Open-market purchase Champions Oncology, Inc.CSBR 6,500, acquired Open Form 4 filing 0001628280-24-001334
2024-01-11 P, Open-market purchase Champions Oncology, Inc.CSBR 12,540, acquired Open Form 4 filing 0001628280-24-001231
2024-01-10 P, Open-market purchase Champions Oncology, Inc.CSBR 18,577, acquired Open Form 4 filing 0001628280-24-001118
2024-01-09 P, Open-market purchase Champions Oncology, Inc.CSBR 18,750, acquired Open Form 4 filing 0001628280-24-001002
2024-01-08 P, Open-market purchase Champions Oncology, Inc.CSBR 6,150, acquired Open Form 4 filing 0001628280-24-000896
2024-01-05 P, Open-market purchase Champions Oncology, Inc.CSBR 12,180, acquired Open Form 4 filing 0001628280-24-000825
2024-01-04 P, Open-market purchase Champions Oncology, Inc.CSBR 18,360, acquired Open Form 4 filing 0001628280-24-000820
2024-01-03 P, Open-market purchase Champions Oncology, Inc.CSBR 2,915, acquired Open Form 4 filing 0001628280-24-000388
2023-12-21 P, Open-market purchase Champions Oncology, Inc.CSBR 12,300, acquired Open Form 4 filing 0001628280-23-042662
2023-12-20 P, Open-market purchase Champions Oncology, Inc.CSBR 10,122, acquired Open Form 4 filing 0001628280-23-042467
2023-12-19 P, Open-market purchase Champions Oncology, Inc.CSBR 23,750, acquired Open Form 4 filing 0001628280-23-042096
2023-10-11 P, Open-market purchase Champions Oncology, Inc.CSBR 32,000, acquired Open Form 4 filing 0001628280-23-034348
2023-10-10 P, Open-market purchase Champions Oncology, Inc.CSBR 7,051, acquired Open Form 4 filing 0001628280-23-034231
2023-10-06 P, Open-market purchase Champions Oncology, Inc.CSBR 9,914, acquired Open Form 4 filing 0001628280-23-034119
2023-10-05 P, Open-market purchase Champions Oncology, Inc.CSBR 12,940, acquired Open Form 4 filing 0001628280-23-034004
2023-10-04 P, Open-market purchase Champions Oncology, Inc.CSBR 32,000, acquired Open Form 4 filing 0001628280-23-033842
2023-10-03 P, Open-market purchase Champions Oncology, Inc.CSBR 15,750, acquired Open Form 4 filing 0001628280-23-033843
2023-09-29 P, Open-market purchase Champions Oncology, Inc.CSBR 24,640, acquired Open Form 4 filing 0001628280-23-034409
2023-09-28 P, Open-market purchase Champions Oncology, Inc.CSBR 31,100, acquired Open Form 4 filing 0001628280-23-034407
2023-09-27 P, Open-market purchase Champions Oncology, Inc.CSBR 8,925, acquired Open Form 4 filing 0001628280-23-034405
2023-09-26 P, Open-market purchase Champions Oncology, Inc.CSBR 28,250, acquired Open Form 4 filing 0001628280-23-033077
2023-09-22 P, Open-market purchase Champions Oncology, Inc.CSBR 20,966, acquired Open Form 4 filing 0001628280-23-032917
2023-09-21 P, Open-market purchase Champions Oncology, Inc.CSBR 27,550, acquired Open Form 4 filing 0001628280-23-032918
2023-09-20 P, Open-market purchase Champions Oncology, Inc.CSBR 22,139, acquired Open Form 4 filing 0001628280-23-032919
2023-09-19 P, Open-market purchase Champions Oncology, Inc.CSBR 26,400, acquired Open Form 4 filing 0001628280-23-032920
2020-03-26 P, Open-market purchase Champions Oncology, Inc.CSBR 5 lines 7,213, acquired Open Form 4 filing 0001628280-20-004374
2020-03-24 P, Open-market purchase Champions Oncology, Inc.CSBR 143, acquired Open Form 4 filing 0001628280-20-004087
2018-11-06 S, Open-market sale Champions Oncology, Inc.CSBR 68,750, disposed Open Form 4 filing 0001628280-18-014013
2018-09-20 S, Open-market sale Champions Oncology, Inc.CSBR 108,496, disposed Open Form 4 filing 0001628280-18-012338
2015-03-11 P, Open-market purchase Champions Oncology, Inc.CSBR Not reported Open Form 4 filing 0001144204-15-016734
2014-03-20 P, Open-market purchase Champions Oncology, Inc.CSBR 105,300, acquired Open Form 4 filing 0001144204-14-017171
2014-03-19 P, Open-market purchase Champions Oncology, Inc.CSBR 2,620, acquired Open Form 4 filing 0001144204-14-017171

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 34
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Mendelson Daniel Newman, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001327897

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.